Corinne has over 15 years of broad experience in both the pharmaceutical and biotech arena. In her current position, she has responsibility for all Business development and partnering deals within Novartis.
After a Ph.D. in Immunology and a number of academic and pharmaceutical research positions, Corinne joined Imutran Ltd a UK based Biotech as Director of Research. In 1996 Imutran was acquired by Novartis and Corinne made the COO. She moved to Basel in 2001 as the CEO of the Novartis Bio Venture Fund, managing a CHF 100 million investment fund. In 2005 Corinne moved to head up Global Search and Evaluation with Novartis Business development where she was responsible for the identification and evaluation of potential license-in or M&A opportunities, growing the Novartis development pipeline and supporting the business goals of Novartis. In 2010 Corinne became Novartis’s Global Head of Pricing and Market Access responsible for the pricing and market access strategies for the portfolio of Novartis Pharma’s development and in Market products world-wide. In June 2013 Corinne was appointed Head Business Development and Licensing Novartis Pharma AG.